Healthcare sector in India had the most violations in advertising rules in 2023-24, with misleading claims being the main issue, according to ASCI report.
The decision was taken during an emergency meeting at the Akal Takht's secretariat, with acting Jathedar Giani Kuldip Singh Gargajj announcing the decision.
In an interview with NDTV, Maharashtra Food and Drug Administration (FDA) commissioner Tukaram Mundhe says two of the three actors have replied to the show-cause notices
Comments
Post a Comment